Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Lucas, SébastienOmata, Yasunori
Hofmann, Jörg
Böttcher, Martin
Iljazovic, Aida
Sarter, Kerstin
Albrecht, Olivia
Schulz, Oscar
Krishnacoumar, Brenda
Krönke, Gerhard
Herrmann, Martin
Mougiakakos, Dimitrios
Strowig, Till
Schett, Georg
Zaiss, Mario M
Issue Date
2018
Metadata
Show full item recordAbstract
Microbial metabolites are known to modulate immune responses of the host. The main metabolites derived from microbial fermentation of dietary fibers in the intestine, short-chain fatty acids (SCFA), affect local and systemic immune functions. Here we show that SCFA are regulators of osteoclast metabolism and bone mass in vivo. Treatment of mice with SCFA as well as feeding with a high-fiber diet significantly increases bone mass and prevents postmenopausal and inflammation-induced bone loss. The protective effects of SCFA on bone mass are associated with inhibition of osteoclast differentiation and bone resorption in vitro and in vivo, while bone formation is not affected. Mechanistically, propionate (C3) and butyrate (C4) induce metabolic reprogramming of osteoclasts resulting in enhanced glycolysis at the expense of oxidative phosphorylation, thereby downregulating essential osteoclast genes such as TRAF6 and NFATc1. In summary, these data identify SCFA as potent regulators of osteoclast metabolism and bone homeostasis.Citation
Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss. 2018, 9 (1):55 Nat CommunAffiliation
Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7, 38124 Braunschweig, Germany.Journal
Nature communicationsPubMed ID
29302038Type
ArticleLanguage
enISSN
2041-1723ae974a485f413a2113503eed53cd6c53
10.1038/s41467-017-02490-4
Scopus Count
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-sa/4.0/
Related articles
- Butyrate Inhibits Osteoclast Activity In Vitro and Regulates Systemic Inflammation and Bone Healing in a Murine Osteotomy Model Compared to Antibiotic-Treated Mice.
- Authors: Wallimann A, Magrath W, Pugliese B, Stocker N, Westermann P, Heider A, Gehweiler D, Zeiter S, Claesson MJ, Richards RG, Akdis CA, Hernandez CJ, O'Mahony L, Thompson K, Moriarty TF
- Issue date: 2021
- Short-chain fatty acids and FFAR2 as suppressors of bone resorption.
- Authors: Montalvany-Antonucci CC, Duffles LF, de Arruda JAA, Zicker MC, de Oliveira S, Macari S, Garlet GP, Madeira MFM, Fukada SY, Andrade I Jr, Teixeira MM, Mackay C, Vieira AT, Vinolo MA, Silva TA
- Issue date: 2019 Aug
- RARγ is a negative regulator of osteoclastogenesis.
- Authors: Green AC, Poulton IJ, Vrahnas C, Häusler KD, Walkley CR, Wu JY, Martin TJ, Gillespie MT, Chandraratna RA, Quinn JM, Sims NA, Purton LE
- Issue date: 2015 Jun
- In vitro fermentation of swine ileal digesta containing oat bran dietary fiber by rat cecal inocula adapted to the test fiber increases propionate production but fermentation of wheat bran ileal digesta does not produce more butyrate.
- Authors: Monsma DJ, Thorsen PT, Vollendorf NW, Crenshaw TD, Marlett JA
- Issue date: 2000 Mar
- Quantification of in Vivo Colonic Short Chain Fatty Acid Production from Inulin.
- Authors: Boets E, Deroover L, Houben E, Vermeulen K, Gomand SV, Delcour JA, Verbeke K
- Issue date: 2015 Oct 28